Updates in the Management of Early Alzheimer’s Disease - a podcast by ReachMD

CME credits: 0.25

Valid until: 07-01-2022

Claim your CME credit at https://reachmd.com/programs/cme/updates-in-the-management-of-early-alzheimers-disease/12091/

Despite decades of research, there are only a handful of FDA-approved drugs available for patients with Alzheimer’s disease (AD). Fortunately, several promising agents for the treatment of AD are in the late stages of development

Join us as Dr. Richard Isaacson and Dr. Marc Agronin take a deeper dive into the important guidelines and advances surrounding the treatment of Alzheimer’s disease.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD